Gateway Analytical and Next Breath Partner to Present Webinar Series Focused on Formulation Development for Inhalable and Nasal Drug Products

TIFANIE TIBERIO | October 7, 2015

article image
The first in a series of four webinars, presented jointly by Gateway Analytical and Next Breath, will offer attendees insight into utilization of ingredient specific particle sizing (ISPS) to support formulation development.

Spotlight

United Family Healthcare

After 21 years of development, United Family Healthcare (UFH) now offers a complete range of medical services including sophisticated surgical and interventional solutions that match top hospitals around the world. A true pioneer in Asia’s healthcare development, we lead the way in international standards of service in high-end, private medical care. With 7 hospitals and 14 satellite clinics in Beijing, Shanghai, Guangzhou, Tianjin, Qingdao, Nanjing, Wuxi, Hangzhou and Bo'ao, UFH is recognized as one of the premium healthcare systems nationwide and is internationally accredited by the Joint Commission International (JCI). There are over 400 full-time doctors from 25 different countries and regions working in UFH. Additionally there are over 1100 part-time experts and over 900 nurses on the team.

OTHER ARTICLES

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | February 11, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | February 11, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Comparing HydroxyChloroquine Trials

Article | February 11, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | February 11, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Spotlight

United Family Healthcare

After 21 years of development, United Family Healthcare (UFH) now offers a complete range of medical services including sophisticated surgical and interventional solutions that match top hospitals around the world. A true pioneer in Asia’s healthcare development, we lead the way in international standards of service in high-end, private medical care. With 7 hospitals and 14 satellite clinics in Beijing, Shanghai, Guangzhou, Tianjin, Qingdao, Nanjing, Wuxi, Hangzhou and Bo'ao, UFH is recognized as one of the premium healthcare systems nationwide and is internationally accredited by the Joint Commission International (JCI). There are over 400 full-time doctors from 25 different countries and regions working in UFH. Additionally there are over 1100 part-time experts and over 900 nurses on the team.

Events